Jessica E. Hutti

2.0k total citations
25 papers, 1.6k citations indexed

About

Jessica E. Hutti is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Jessica E. Hutti has authored 25 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Hematology and 8 papers in Cancer Research. Recurrent topics in Jessica E. Hutti's work include NF-κB Signaling Pathways (7 papers), Chronic Myeloid Leukemia Treatments (6 papers) and interferon and immune responses (5 papers). Jessica E. Hutti is often cited by papers focused on NF-κB Signaling Pathways (7 papers), Chronic Myeloid Leukemia Treatments (6 papers) and interferon and immune responses (5 papers). Jessica E. Hutti collaborates with scholars based in United States, United Kingdom and Australia. Jessica E. Hutti's co-authors include Lewis C. Cantley, Derek W. Abbott, Benjamin E. Turk, John M. Asara, Alex Toker, James D. Chang, Peter Störz, Michelle A. Kelliher, Yibin Yang and Swetha Madhavarapu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Jessica E. Hutti

23 papers receiving 1.6k citations

Peers

Countries citing papers authored by Jessica E. Hutti

Since Specialization

Citations

This map shows the geographic impact of Jessica E. Hutti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jessica E. Hutti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jessica E. Hutti more than expected).

Fields of papers citing papers by Jessica E. Hutti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jessica E. Hutti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jessica E. Hutti. The network helps show where Jessica E. Hutti may publish in the future.

Co-authorship network of co-authors of Jessica E. Hutti

This figure shows the co-authorship network connecting the top 25 collaborators of Jessica E. Hutti. A scholar is included among the top collaborators of Jessica E. Hutti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jessica E. Hutti. Jessica E. Hutti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Treatment Patterns and Overall Survival (OS) Among Patients with Myelodysplastic Syndromes (MDS) Treated in the US Community Oncology Setting: A Real-World Retrospective Observational Study 2022 ·Blood ·Roger M. Lyons, Wei‐Han Cheng, (unknown), Ping Shi, (unknown), Cat N. Bui, Jessica E. Hutti, Ann McNeill, Elizabeth S. Mearns, (unknown), (unknown)	0
2	Safety, Efficacy, and Patient-Reported Outcomes of Venetoclax in Combination with Azacitidine for the Treatment of Patients with Higher-Risk Myelodysplastic Syndrome: A Phase 1b Study 2020 ·Blood ·Jacqueline S. Garcia, Andrew H. Wei, Uma Borate, Chun Yew Fong, Maria R. Baer, Florian Nolte, Joseph G. Jurcic, Meagan A. Jacoby, Wan‐Jen Hong, Uwe Platzbecker, Olatoyosi Odenike, Ilona Cunningham, Ying Zhou, Bo Tong, Leah J. Hogdal, (unknown), Jessica E. Hutti, (unknown), Guillermo Garcia‐Manero	36
3	The Addition of Navitoclax to Ruxolitinib Demonstrates Efficacy within Different High-Risk Populations in Patients with Relapsed/Refractory Myelofibrosis 2020 ·Blood ·Naveen Pemmaraju, Jacqueline S. Garcia, Jalaja Potluri, Leanne Holes, Jason G. Harb, Paul Jung, Jessica E. Hutti, Josef T. Prchal, Srđan Verstovšek, Claire Harrison	22
4	Oncogenic PI3K Mutations Lead to NF- B-Dependent Cytokine Expression following Growth Factor Deprivation 2020 ·UNC Libraries ·(unknown), (unknown), Adam D. Pfefferle, Albert S. Baldwin, Jessica E. Hutti, Charles M. Perou	0
5	MPN-038: Navitoclax in Combination with Ruxolitinib in Patients with Primary or Secondary Myelofibrosis: A Phase 2 Study 2020 ·Clinical Lymphoma Myeloma & Leukemia ·Claire Harrison, Jacqueline S. Garcia, Ruben A. Mesa, Tim C. P. Somervaille, Ellen K. Ritchie, Rami S. Komrokji, Naveen Pemmaraju, Catriona Jamieson, Nikolaos Papadantonakis, James M. Foran, Casey L. O’Connell, Srđan Verstovšek, Paul Jung, Leanne Holes, (unknown), Jason G. Harb, Jessica E. Hutti, Josef T. Prchal	5
6	A Phase 3, Double-Blind, Placebo-Controlled, Randomized Study Evaluating Navitoclax in Combination with Ruxolitinib in Patients with Myelofibrosis (TRANSFORM-1) 2020 ·Blood ·Jalaja Potluri, Jason G. Harb, (unknown), Jessica E. Hutti	14
7	First-in-Human Study of Mivebresib (ABBV-075), an Oral Pan-Inhibitor of Bromodomain and Extra Terminal Proteins, in Patients with Relapsed/Refractory Solid Tumors 2019 ·Clinical Cancer Research ·Sarina A. Piha‐Paul, Jasgit C. Sachdev, Minal Barve, Patricia LoRusso, Russell Z. Szmulewitz, Sapna P. Patel, Primo N. Lara, (unknown), Beibei Hu, Kevin J. Freise, Dimple Modi, Anjla Sood, Jessica E. Hutti, Johannes Wolff, Bert H. O’Neil	116
8	VHL Synthetic Lethality Signatures Uncovered by Genotype-Specific CRISPR-Cas9 Screens 2019 ·The CRISPR Journal ·Ning Sun, Sakina Petiwala, Charles Lu, Jessica E. Hutti, Min Hu, Mufeng Hu, Marc Domanus, (unknown), Sadiya N. Addo, Christopher P. Miller, Namjin Chung	10
9	Novel Modes of Inhibition of Wild-Type Isocitrate Dehydrogenase 1 (IDH1): Direct Covalent Modification of His315 2018 ·Journal of Medicinal Chemistry ·Clarissa G. Jakob, Anup K. Upadhyay, (unknown), (unknown), Sadiya N. Addo, Wei Qiu, Chris Ling, Sujatha M. Gopalakrishnan, Maricel Torrent, Steven Cepa, (unknown), Alexander R. Shoemaker, Chaohong Sun, Anil Vasudevan, Kevin R. Woller, J. Brad Shotwell, Bailin Shaw, Zhiguo Bian, Jessica E. Hutti	34
10	Cytosolic DNA Promotes Signal Transducer and Activator of Transcription 3 (STAT3) Phosphorylation by TANK-binding Kinase 1 (TBK1) to Restrain STAT3 Activity 2017 ·Journal of Biological Chemistry ·(unknown), Jessica E. Hutti, Albert S. Baldwin	26
11	Oncogenic PI3K Mutations Lead to NF-κB–Dependent Cytokine Expression following Growth Factor Deprivation 2012 ·Cancer Research ·Jessica E. Hutti, Adam D. Pfefferle, (unknown), (unknown), Charles M. Perou, Albert S. Baldwin	61
12	Development of a High-Throughput Assay for Identifying Inhibitors of TBK1 and IKKε 2012 ·PLoS ONE ·Jessica E. Hutti, (unknown), (unknown), Lewis C. Cantley, Xiaodong Wang, Dmitri Kireev, Albert S. Baldwin, William P. Janzen	31
13	p85α SH2 Domain Phosphorylation by IKK Promotes Feedback Inhibition of PI3K and Akt in Response to Cellular Starvation 2012 ·Molecular Cell ·William C. Comb, Jessica E. Hutti, Patricia C. Cogswell, Lewis C. Cantley, A S Baldwin	60
14	Phosphorylation of the Tumor Suppressor CYLD by the Breast Cancer Oncogene IKKɛ Promotes Cell Transformation 2009 ·Molecular Cell ·Jessica E. Hutti, Rhine R. Shen, Derek W. Abbott, Alicia Y. Zhou, Kam Sprott, John M. Asara, William C. Hahn, Lewis C. Cantley	184
15	Development of an intracellularly acting inhibitory peptide selective for PKN 2009 ·Biochemical Journal ·(unknown), Kentaro Takayama, Shiroh Futaki, Jessica E. Hutti, Lewis C. Cantley, (unknown), Yoshitaka Ono, Hideyuki Mukai	17
16	Evolution of Ime2 Phosphorylation Sites on Cdk1 Substrates Provides a Mechanism to Limit the Effects of the Phosphatase Cdc14 in Meiosis 2007 ·Molecular Cell ·Liam J. Holt, Jessica E. Hutti, Lewis C. Cantley, David O. Morgan	60
17	Coordinated Regulation of Toll-Like Receptor and NOD2 Signaling by K63-Linked Polyubiquitin Chains 2007 ·Molecular and Cellular Biology ·Derek W. Abbott, Yibin Yang, Jessica E. Hutti, Swetha Madhavarapu, Michelle A. Kelliher, Lewis C. Cantley	150
18	Determining protein kinase substrate specificity by parallel solution-phase assay of large numbers of peptide substrates 2006 ·Nature Protocols ·Benjamin E. Turk, Jessica E. Hutti, Lewis C. Cantley	60
19	Building a human kinase gene repository: Bioinformatics, molecular cloning, and functional validation 2005 ·Proceedings of the National Academy of Sciences ·Jae-Hong Park, Yanhui Hu, Tal V. Murthy, Fredrik Vannberg, Binghua Shen, Andreas Rolfs, Jessica E. Hutti, Lewis C. Cantley, Joshua LaBaer, Ed Harlow, Leonardo Brizuela	34
20	A rapid method for determining protein kinase phosphorylation specificity 2004 ·Nature Methods ·Jessica E. Hutti, (unknown), James D. Chang, Derek W. Abbott, Peter Störz, Alex Toker, Lewis C. Cantley, Benjamin E. Turk	287

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact